| Abstrakt: |
A recent study conducted by researchers at Mansoura University in Egypt investigated the effects of vanillic acid (VA) on a Cuprizone-induced multiple sclerosis rat model. The study found that VA had a neuroprotective effect, improving nerve conduction velocity and reducing demyelination in the sciatic nerve. The researchers also observed a reduction in inflammation, oxidative stress, and apoptosis with VA treatment. These findings suggest that VA may have potential therapeutic benefits for multiple sclerosis. [Extracted from the article] |
